• MS & Me
  • MS Info Hub
  • MS News
  • MS Radio

Novartis multiple sclerosis drug Gilenya shows siginificant effect against pediatric MS in phase III...

Novartis MS Drug Gilenya shows siginificant effect in phase III trial: Against Pediatric MSNovartis’ multiple sclerosis (MS) drug Gilenya (fingolimod) has demonstrated significant effect...

Social Media

531FollowersFollow